“…Recently, accumulated studies have elucidated that ubiquitination/deubiquitination post‐translational modification system functions as an important approach to regulate metabolic reprogramming and metabolic enzymes in diverse cancer types. 37 , 38 , 39 Despite E3 ligases, like FBXW7, Malin and Nedd4, 40 , 41 , 42 and deubiquitinase, like PSMD14, 43 are involved in regulating ubiquitination and proteasome‐dependent degradation of PKM2, the E3 ligase Parkin‐mediated PKM2 ubiquitination markedly abrogates the enzymatic activity of PKM2 without an effect on its protein stability, which may be reversed by deubiquitinase OTUB2, 34 , 35 suggesting that the regulatory mechanism on PKM2 enzymatic activity and expression level by ubiquitination is complex and largely context‐dependent. Therefore, the core factors being critical for modulating the biological function of PKM2 in GCs remain to be explored.…”